Jim has over 30 years of drug discovery and research management experience. He currently serves on the board of directors, scientific advisory board and as an advisor to several biotechnology companies and venture capital firms. Previously, Jim was Vice President of Neuroscience Research at AbbVie, where he led global efforts focused on the discovery of new drugs for neurodegenerative diseases. Under his leadership more than twenty drugs entered clinical development.
This person is not in the org chart